WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People With HIV in Peru

Brief summary (registry, in English)

The goal of this clinical trial is to learn which type of messages is more efficacious to improve adherence to medication in young people living with HIV. The main question is aims to answer is: -Are messages designed by participants (self-designed) more efficacious than messages designed by health providers to improve adherence to antiretroviral treatment (HIV medications)? Researchers will compare both types of messages to see if one is better than the other in helping participants take their medications. Participants will: * Receive either messages designed by themselves or by health providers for 4 months. * Be able to chat with health providers at any time, with special focus regarding questions about their condition, medications and health services. * Complete questionnaires via WhatsApp describing how they are taking their medications, and how often they forget to take them. * Complete questionnaires via WhatsApp describing their opinion about receiving the messages and being able to chat with health providers.

What you commit to

• Study type: Interventional
• Planned participants: 131
• From 15 Mar 2024 to the primary completion date, 18 Nov 2024
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 29 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.